Elucidating the role of FGFR2 activation and RUNX2 expression in the progression of luminal breast cancer
Invasive mammary carcinomas with different progesterone receptor isoform ratios: metastatic vs. proliferative ability, which is worse?
ANDROGEN RECEPTORS AND WNT PATHWAY AS THERAPEUTIC TARGETS IN ENDOCRINE RESISTANT BREAST CANCER MODELS
Combination of GnRH Agonist/Antagonist with Protein Kinase Inhibitors Counteracts Growth and Metastasis in Breast Cancer
Seeking the Truth Behind the Myth: Nuclear Role for Argonaute-1 as an Estrogen-Dependent Enhancer Coactivator